Quantinno Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
46,322
+7,897
| +21% | +$3.52M | 0.09% | 249 |
|
|
2025
Q1 | $18.6M | Buy |
38,425
+14,349
| +60% | +$6.96M | 0.12% | 167 |
|
|
2024
Q4 | $9.7M | Buy |
24,076
+4,381
| +22% | +$1.76M | 0.1% | 212 |
|
|
2024
Q3 | $9.16M | Buy |
19,695
+5,238
| +36% | +$2.44M | 0.12% | 154 |
|
|
2024
Q2 | $6.78M | Buy |
14,457
+1,692
| +13% | +$793K | 0.12% | 147 |
|
|
2024
Q1 | $5.34M | Buy |
12,765
+1,896
| +17% | +$793K | 0.12% | 174 |
|
|
2023
Q4 | $4.42M | Buy |
10,869
+1,494
| +16% | +$608K | 0.15% | 126 |
|
|
2023
Q3 | $3.26M | Buy |
9,375
+1,804
| +24% | +$627K | 0.15% | 144 |
|
|
2023
Q2 | $2.66M | Buy |
7,571
+3,754
| +98% | +$1.32M | 0.15% | 153 |
|
|
2023
Q1 | $1.2M | Sell |
3,817
-164
| -4% | -$51.7K | 0.08% | 324 |
|
|
2022
Q4 | $1.15M | Buy |
3,981
+2,573
| +183% | +$743K | 0.09% | 319 |
|
|
2022
Q3 | $408K | Buy |
1,408
+250
| +22% | +$72.4K | 0.05% | 421 |
|
|
2022
Q2 | $326K | Buy |
+1,158
| New | +$326K | 0.05% | 438 |
|